Cargando…
Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
As survival of acute lymphoblastic leukemia (ALL) exceeds 90%, limiting therapy-related toxicity has become a key challenge. Cardio-metabolic dysfunction is a challenge during and after childhood ALL therapy. In a single center study, we measured triglycerides (TG), total cholesterol (TC), high (HDL...
Autores principales: | Mogensen, Pernille Rudebeck, Grell, Kathrine, Schmiegelow, Kjeld, Overgaard, Ulrik Malthe, Wolthers, Benjamin Ole, Mogensen, Signe Sloth, Vaag, Allan, Frandsen, Thomas Leth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135240/ https://www.ncbi.nlm.nih.gov/pubmed/32251440 http://dx.doi.org/10.1371/journal.pone.0231209 |
Ejemplares similares
-
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy
por: Schmiegelow, Kjeld, et al.
Publicado: (2017) -
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
por: Larsen, Rikke Hebo, et al.
Publicado: (2021) -
Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014) -
Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review
por: Toksvang, Linea Natalie, et al.
Publicado: (2019) -
Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion
por: Baruchel, André, et al.
Publicado: (2020)